1. Introduction {#sec1-marinedrugs-15-00011}
===============

Since the isolation in 1972 of the first marine 9,11-secosteroid, 9-oxo-9,11-secogorgost-5-ene-3*β*, 11-diol 11-acetate, from the gorgonian coral *Pseudopterogorgia americana* \[[@B1-marinedrugs-15-00011]\], a series of compounds of this group has been prepared from various marine invertebrates, particularly sponges and octocorals, with complex structures and interesting bioactivities \[[@B2-marinedrugs-15-00011]\]. Our continued investigations of gorgonian coral *Pinnigorgia* sp. (phylum Cnidaria, class Anthozoa, subclass Octocorallia, order Alcyonacea, family Gorgoniidae) have yielded various interesting secondary metabolites \[[@B3-marinedrugs-15-00011],[@B4-marinedrugs-15-00011],[@B5-marinedrugs-15-00011],[@B6-marinedrugs-15-00011],[@B7-marinedrugs-15-00011],[@B8-marinedrugs-15-00011]\], including 9,11-secosterols \[[@B3-marinedrugs-15-00011],[@B4-marinedrugs-15-00011],[@B5-marinedrugs-15-00011]\], some of which have been shown to possess bioactivity, such as anti-inflammatory and cytotoxic properties \[[@B3-marinedrugs-15-00011],[@B4-marinedrugs-15-00011],[@B5-marinedrugs-15-00011],[@B6-marinedrugs-15-00011],[@B7-marinedrugs-15-00011],[@B8-marinedrugs-15-00011]\]. With the aim of discovering bioactive marine metabolites for new drug development in the future, we carried out an investigation of the chemical composition of the gorgonian coral *Pinnigorgia* sp. In this study, we performed compound preparation and structure determination, and investigated the cytotoxicity and anti-inflammatory activities of seven new 9,11-secosterols, pinnisterols D--J (**1**--**7**), following further study of *Pinnigorgia* sp. ([Figure 1](#marinedrugs-15-00011-f001){ref-type="fig"}).

2. Results and Discussion {#sec2-marinedrugs-15-00011}
=========================

A new metabolite was isolated as a colorless oil, and was named pinnisterol D (**1**). The high-resolution electrospray ionization mass spectrum (HRESIMS) showed a signal at *m/z* 525.31853 (calcd. for C~30~H~46~O~6~ + Na, 525.31921), and therefore the molecular formula of **1** was determined to be C~30~H~46~O~6~ (8° of unsaturation). ^13^C and distortionless enhancement polarization transfer (DEPT) experimental data indicated that **1** had 30 carbons, including seven methyls, seven sp^3^ methylenes (including one oxymethylene), six sp^3^ methines (including one oxymethine), two sp^3^ quaternary carbons, one sp^3^ tertiary alcohol, three sp^2^ methines, one sp^2^ tertiary carbon, two ketonic carbonyls, and one ester carbonyl ([Table 1](#marinedrugs-15-00011-t001){ref-type="table"}). In addition, IR spectroscopy demonstrated that the compound contained hydroxy (ν~max~ 3446 cm^−1^), ester (ν~max~ 1741 cm^−1^), and *α*,*β*-unsaturated ketonic carbonyl (ν~max~ 1685 cm^−1^) groups. The latter structural feature of **1** was further proven by the presence of signals at δ~C~ 197.5 (C-6), 134.1 (CH-7), 152.0 (C-8), and 201.6 (C-9) in the ^13^C NMR spectrum. Signals of carbons at δ~C~ 133.8 (CH-22) and 133.5 (CH-23) suggested the existence of a disubstituted olefin, and this was confirmed by two olefin proton signals at δ~H~ 5.26 (1H, dd, *J* = 14.8, 6.8 Hz, H-23) and 5.23 (1H, dd, *J* = 14.8, 6.8 Hz, H-22) ([Table 1](#marinedrugs-15-00011-t001){ref-type="table"}). The presence of Me-21, Me-28, Me-26, and Me-27 groups resulted in four doublets located at δ~H~ 1.05 (3H, *J* = 6.8 Hz), 0.91 (3H, *J* = 6.8 Hz), 0.84 (3H, *J* = 7.2 Hz), and 0.82 (3H, *J* = 7.2 Hz), respectively, and the existence of H~3~-18 and H~3~-19 resulted in two sharp singlets at δ~H~ 0.73 and δ~H~ 1.21, respectively. In the ^1^H NMR spectrum, one acetyl methyl signal (δ~H~ 2.02, 3H, s) was observed. Based on the aforementioned findings, metabolite **1** was determined to be a tricyclic compound.

From the ^1^H NMR spectrum and ^1^H--^1^H correlation spectroscopy (COSY) of **1** ([Table 1](#marinedrugs-15-00011-t001){ref-type="table"}), the following correlations were revealed: H~2~-1/H~2~-2/H-3/H~2~-4, H~2~-11/H~2~-12, H-14/H~2~-15/H~2~-16/H-17/H-20/H-22/H-23/H-24/H-25/H~3~-26, H-20/H~3~-21, H-24/H~3~-28, and H-25/H~3~-27. Together with data of key heteronuclear multiple bond coherence (HMBC) correlations between H~2~-4, H-7, H~3~-19/C-5; H~2~-4/C-6; H-7, H-14/C-8; H-7, H-14, H~3~-19/C-9; H~2~-1, H~2~-4, H~3~-19/C-10; and H~2~-11, H~2~-12, H-14, and H~3~-18/C-13, all the information allowed determination of the main carbon skeleton of **1** ([Table 1](#marinedrugs-15-00011-t001){ref-type="table"}).

The correlations identified using nuclear Overhauser effect spectroscopy (NOESY) in addition to comparison of NMR data with those of known 9,11-secosterol **8**, isolated from Korean marine sponge *Ircinia* sp. \[[@B9-marinedrugs-15-00011]\], and pinnisterol A (**9**) \[[@B4-marinedrugs-15-00011]\], enabled clarification of the configuration of **1** ([Figure 1](#marinedrugs-15-00011-f001){ref-type="fig"}). The stereochemistries of stereogenic centers C-3, C-5, C-10, C-13, C-14, and C-17 in **1** were the same as those of **8**. In addition, the main NOE correlations for **1** were interactions between H-3/H-2*α* (δ~H~ 2.00), H-2*β* (δ~H~ 1.49)/H~3~-19, H-3/H-4*α* (δ~H~ 2.17), H-4*β* (δ~H~ 1.79)/H~3~-19; thus, H-3 and the 5-hydroxy group in **1** should be positioned on the α-face ([Figure 2](#marinedrugs-15-00011-f002){ref-type="fig"}).

There was a greater coupling constant between H-22 and H-23 (*J* = 14.8 Hz), which supported a *trans* relationship between H-22 and H-23. This implied that the configuration of C-24 should be *R* according to the ^13^C NMR chemical shift of C-28 (δ~C~ 17.5). A previous study showed that, for a known sterol, (22*E*,24*R*)-24-methylcholesta-5,22-dien-3*β*-ol, with an identical chain, and the 24*S* epimer, (22*E*,24*S*)-24-methylcholesta-5,22-dien-3*β*-ol, the ^13^C NMR value of C-28 resonates at δ~C~ 17.68 ppm in the 24*R* epimer, with a relative 0.4 ppm downfield chemical shift ([Figure 3](#marinedrugs-15-00011-f003){ref-type="fig"}) \[[@B10-marinedrugs-15-00011]\].

Pinnisterol E (**2**) was present as a colorless oil. From HRESIMS analysis, the signal at *m/z* 527.33410 (calcd. for C~30~H~48~O~6~ + Na, 527.33486) suggested the molecular formula of **2** to be C~30~H~48~O~6~ (7° of unsaturation), and the IR spectrum demonstrated the existence of hydroxy (ν~max~ 3381 cm^−1^), ester (ν~max~ 1740 cm^−1^), and *α*,*β*-unsaturated ketonic carbonyl (ν~max~ 1686 cm^−1^) groups. The whole series of spectroscopic data demonstrated that secosterols **2** and **1** had an identical core structure, the difference being limited to the absence in **2** of the carbon-carbon double bond between C-22/23. The complete assignments of ^1^H and ^13^C NMR of **2** ([Table 2](#marinedrugs-15-00011-t002){ref-type="table"} and [Table 3](#marinedrugs-15-00011-t003){ref-type="table"}) were compared with the values of **1**, and secosterol **2** was assigned as having structure **2**, with the same configurations of the core rings A--C. In addition, both compounds had identical stereogenic centers at C-3, C-5, C-10, C-13, C-14, and C-17, and their ^1^H and ^13^C NMR chemical shifts and proton coupling constants were in concurrence also. Based on the ^13^C NMR chemical shifts of C-25 (δ~C~ 31.5), C-26 (δ~C~ 17.6), and C-27 (δ~C~ 20.5), the configuration of the stereogenic center at C-24 was assigned as *S*. Previous study also showed that the ^13^C NMR values of C-25, C-26, and C-27 resonates at δ~C~ 31.54, 17.68, and 20.56 ppm in a 24*S* epimer of a known sterol, (24*S*)-24-methylcholest-5-en-3*β*-ol, with an identical side chain, and the ^13^C NMR values of C-25, C-26, and C-27 in a 24*R* epimer, (24*R*)-24-methylcholest-5-en-3*β*-ol, were observed at δ~C~ 32.49, 20.26, and 18.32 ppm, respectively ([Figure 4](#marinedrugs-15-00011-f004){ref-type="fig"}) \[[@B10-marinedrugs-15-00011]\].

Pinnisterol F (**3**) was present as a colorless oil. From HRESIMS analysis, the signal at *m/z* 583.32406 (calcd. for C~32~H~48~O~8~ + Na, 583.32469) suggested the molecular formula of **3** to be C~32~H~48~O~8~ (9° of unsaturation). The NMR signals of **3** ([Table 2](#marinedrugs-15-00011-t002){ref-type="table"} and [Table 3](#marinedrugs-15-00011-t003){ref-type="table"}) were similar to those of **1**, except that the signals related to the C-21 methyl in **1** were substituted by signals for an acetoxymethylene group in **3**. From the HMBC spectrum of **3**, it was revealed that an ester carbonyl carbon at δ~C~ 171.1 correlated with a methyl signal at δ~H~ 2.04 and a pair of oxygenated methylene protons at δ~H~ 4.01 (1H, dd, *J* = 10.5, 7.0 Hz) and 3.96 (1H, dd, *J* = 10.5, 7.0 Hz), which revealed that an acetoxy group was at the position C-21 in the side chain of **3**. Thus, pinnisterol F (**3**) was found to be the 21-acetoxy derivative of **1**.

Pinnisterol G (**4**) had a molecular formula identical to that of **3**, C~32~H~48~O~8~, with a HRESIMS signal located at *m/z* 583.32432 (calcd. for C~32~H~48~O~8~ + Na, 583.32469) with nine degrees of unsaturation, indicating that secosterols **3** and **4** were isomers. Comparison of the NMR data of **4** with those of **3** ([Table 2](#marinedrugs-15-00011-t002){ref-type="table"} and [Table 3](#marinedrugs-15-00011-t003){ref-type="table"}) showed that both compounds possessed the same sterol nucleus and a similar side chain, but differed in terms of the location of one acetoxy group. From an HMBC experiment, it was revealed that one ester carbonyl carbon at δ~C~ 171.3 correlated with one methyl signal at δ~H~ 2.07 and a pair of oxymethylene protons signals at δ~H~ 3.98 (dd, *J* = 10.5, 6.3 Hz) and 3.85 (dd, *J* = 10.5, 6.3 Hz), which indicated that an acetoxy group was located at C-27 in the side chain. The configurations at C-24 and C-25 were therefore designated as *S*- and *R*-forms, respectively, on the basis of the ^13^C NMR chemical shifts of C-24 (δ~C~ 38.2), C-25 (δ~C~ 37.4), C-26 (δ~C~ 13.1), C-27 (δ~C~ 67.9), and C-28 (δ~C~ 18.3). It was reported that the ^13^C NMR values of C-24, C-25, C-26, C-27, and C-28 resonate at δ~C~ 38.2, 37.6, 13.0, 68.1, and 18.6 ppm in a 24*S* and a 25*R* epimer of a known sterol, echrebsteroid C, with the same side chain, and the ^13^C NMR values of C-24, C-25, C-26, C-27, and C-28 in a 24*S* and 25*S* epimer, echrebsteroid B, appeared at *δ*~C~ 38.8, 37.5, 14.1, 67.9, and 17.1 ppm ([Figure 5](#marinedrugs-15-00011-f005){ref-type="fig"}) \[[@B11-marinedrugs-15-00011]\].

Pinnisterol H (**5**) was isolated as a colorless oil. Based on the HRESIMS signal located at *m/z* 585.33988 (calcd. for C~32~H~50~O~8~ + Na, 585.34034), it was concluded that the molecular formula of **5** was C~32~H~50~O~8~ (8° of unsaturation). The IR spectrum of **5** indicated the presence of hydroxy (ν~max~ 3448 cm^−1^), ester (ν~max~ 1736 cm^−1^) and *α*,*β*-unsaturated ketonic carbonyl (ν~max~ 1686 cm^−1^) groups. The whole series of spectroscopic data showed that secosterol **5** and secosterol **1** shared the same core structure, with the exception of the addition of an acetoxy group to substitute the alkene at C-23 in **5**. The complete assignments of the ^13^C and ^1^H NMR of pinnisterol H (**5**) ([Table 3](#marinedrugs-15-00011-t003){ref-type="table"} and [Table 4](#marinedrugs-15-00011-t004){ref-type="table"}) were compared with the values of **1**, and the HMBC correlations fully supported the positions of the functional groups of **5**, indicating that it had a structure of the same configuration as secosterols **1**--**4** in the core rings A--C. The proton coupling constants and NMR chemical shift data also further supported this finding, though the configurations of C-23 and C-24 were not determined at this stage.

Pinnisterol I (**6**) was obtained as a colorless oil. The HRESIMS signal at *m/z* 585.33988 (calcd. for C~32~H~50~O~8~ + Na, 585.34034) suggested the molecular formula of **6** to be C~32~H~50~O~8~ (8° of unsaturation). The NMR signals of **6** ([Table 3](#marinedrugs-15-00011-t003){ref-type="table"} and [Table 4](#marinedrugs-15-00011-t004){ref-type="table"}) were very similar to those of **5**, with the exception that **5** had signals corresponding to 3-hydroxy and 23-acetoxy groups, which were substituted by signals for acetoxy and hydroxy groups, respectively, in **6**. From a NOESY experiment, the correlations of data of **5** and **6** demonstrated that the configurations of the stereogenic centers in the core rings A--C were identical to those of **1**. The configurations of stereogenic centers C-23 and C-24 of **6** were also not determined at this stage.

Pinnisterol J (**7**) was obtained as a colorless oil and had the molecular formula C~32~H~48~O~8~, as determined by the HRESIMS signal at *m/z* 583.32433 (calcd. for C~32~H~48~O~8~ + Na, 583.32469) (9° of unsaturation). According to the NMR spectroscopic data ([Table 3](#marinedrugs-15-00011-t003){ref-type="table"} and [Table 4](#marinedrugs-15-00011-t004){ref-type="table"}), compound **7** showed the same nuclear structure as that of compound **6**. In the ^13^C NMR data of **7**, one additional disubstituted olefin was identified from signals of carbons at δ~C~ 132.9 (CH-22) and 134.5 (CH-23). The presence of a 24-hydroxy group was evidenced by HMBC correlations between H-22, H-23, H-25, H~3~-26, H~3~-27, and H~3~-28/C-24 (δ~C~ 75.0), a methyl-containing oxygenated tertiary carbon. There was a greater coupling constant between H-22 and H-23 (*J* = 15.6 Hz), suggesting that a *trans* relationship existed between H-22 and H-23. The configuration of the C-24 stereogenic center was assigned as *S* on the basis of the ^13^C NMR chemical shifts of C-24 (δ~C~ 75.0), C-25 (δ~C~ 38.1), C-26 (δ~C~ 17.5), C-27 (δ~C~ 17.1), and C-28 (δ~C~ 25.2). It was reported that the ^13^C NMR values of C-24, C-25, C-26, C-27, and C-28 resonates at δ~C~ 75.1, 38.3, 17.7, 17.4, and 25.2 ppm in a 24*S* epimer of a known synthetic product, 24(*S*)-hydroxyvitamin D~2~, with the same side chain ([Figure 6](#marinedrugs-15-00011-f006){ref-type="fig"}) \[[@B12-marinedrugs-15-00011]\].

The hepatic stellate cell, a major cell type involved in liver fibrosis, is also responsible for liver damage by increasing proliferation and protein secretion associated with the formation of scar tissue. In cytotoxicity testing, secosterols **1**--**7** were examined in terms of their cytotoxic effects on HSC-T6, an immortalized rat hepatic stellate cell lines. At a concentration of 10 μM, secosterols **1**, **3**, and **5** significantly decreased the viability of HSC-T6 cells to 16.8 (IC~50~ = 3.93 μM), 56.9 and 37.1%, respectively ([Figure 7](#marinedrugs-15-00011-f007){ref-type="fig"}). These results implied that the functional groups in the side chain of secosterols **1**--**7** play important roles in determining the activity of the compounds.

In anti-inflammatory testing, secosterols **2**, **5**, and **7** displayed inhibitory effects on the release of elastase (IC~50~ = 2.33, 2.59 and 3.89 μM, respectively), and secosterols **3**, **5**, and **7** showed inhibitory effects on human neutrophils in terms of the generation of superoxide anions (IC~50~ = 5.52, 3.26, and 3.71 μM, respectively) ([Table 5](#marinedrugs-15-00011-t005){ref-type="table"}).

3. Experimental Section {#sec3-marinedrugs-15-00011}
=======================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-15-00011}
------------------------------------

Optical rotations were measured with a digital polarimeter (P-1010; Japan Spectroscopic Corporation, Tokyo, Japan); and infrared spectra were recorded on a spectrometer (FT/IR-4100; Japan Spectroscopic Corporation); peaks are reported in cm^−1^. NMR spectra were obtained on a 400 MHz NMR spectrometer (Mercury Plus; Varian, Palo Alto, CA, USA) and a 700 MHz NMR spectrometer (AVIIIHD700X; Bruker, Bremen, Germany), using the residual CHCl~3~ signal (δ~H~ 7.26 ppm) and CDCl~3~ (δ~C~ 77.1 ppm) as internal standards for ^1^H NMR and ^13^C NMR, respectively. Coupling constant values (*J*) are given in Hz. ESIMS and HRESIMS were performed using mass spectrometry (Tesla solariX FTMS system, Bruker). TLC was carried out on Kieselgel 60 F~254~ precoated plates (0.25 mm, Merck, Darmstadt, Germany), and spots were visualized by the standard method. Column chromatography was performed on silica gel at a size of 230--400 mesh (Merck). HPLC experiments were performed using the following systems: normal-phase HPLC (NP-HPLC) injection port, 7725 (Rheodyne, Rohnert Park, CA, USA); pump, L-7110 (Hitachi, Tokyo, Japan); and semi-preparative normal-phase column (Supelco Ascentis Si Cat \#:581515-U, 25 cm × 21.2 mm, 5 μm, Sigma-Aldrich, St. Louis, MO, USA). Reverse-phase HPLC (RP-HPLC) injection port (7725; Rheodyne); pump, L-2130 (Hitachi); photodiode array detector (L-2455; Hitachi); and reverse-phase column (25 cm × 21.2 mm, Luna 5 μm C18(2) 100 Å, AXIA Packed; Phenomenex, Torrance, CA, USA).

3.2. Animal Material {#sec3dot2-marinedrugs-15-00011}
--------------------

Specimens of gorgonian coral *Pinnigorgia* sp. were collected in August 2012 by hand while scuba diving off the coast of Green Island located near the southeast of Taiwan. The samples were then stored in a freezer until extraction. A voucher specimen was deposited in the National Museum of Marine Biology & Aquarium, Taiwan (specimen No.: NMMBA-TW-GC-2012-130). Identification of the species of this organism was done by comparison as described in the previous publication \[[@B13-marinedrugs-15-00011]\].

3.3. Extraction and Separation {#sec3dot3-marinedrugs-15-00011}
------------------------------

Extraction of compounds was performed at room temperature unless otherwise specified. *Pinnigorgia* sp. (wet weight 1.98 kg; dry weight 0.86 kg) was sliced, and the sliced bodies were then extracted with ethyl acetate (EtOAc). The EtOAc extract (84.9 g) was partitioned with *n*-hexane and methanol (MeOH). The MeOH layer (12.6 g) was separated on a Sephadex LH-20 column and elution was performed using a solvent mixture dichloromethane (DCM):MeOH (1:1); the separation yielded 7 subfractions A--G. Fraction F was separated by silica gel column chromatography and then eluted with *n*-hexane/acetone (stepwise, 50/50 %v/v to 100% acetone) to afford eight subfractions F1--F8. Fraction F2 was purified by silica gel column chromatography and then eluted with *n*-hexane/acetone (stepwise, 90/10 %v/v to 100% acetone) to yield 13 subfractions F2A--F2M. Fraction F2F was purified by NP-HPLC using a mixture of *n*-hexane/EtOAc (5:2) to afford 14 subfractions F2F1--F2F14. Fractions F2F5 and F2F6 were repurified by RP-HPLC using a mixture of MeOH/H~2~O (90/10 %v/v at 5.0 mL/min flow rate) to yield **6** (1.8 mg) and **7** (4.8 mg), respectively. Fraction F2H was purified by NP-HPLC using a mixture of *n*-hexane/EtOAc (50/50 %v/v) to yield 14 subfractions F2H1--F2H14. Fractions F2H9 and F2H10 were repurified by RP-HPLC using a mixture of MeOH/H~2~O (90/10 %v/v at 5.0 mL/min flow rate) to yield **1** (3.8 mg) and **2** (1.5 mg), respectively. Fraction F2I was repurified by NP-HPLC using a mixture of *n*-hexane/EtOAc (50/50 %v/v at 3.0 mL/min flow rate) to afford 15 subfractions F2I1--F2I15, including compound **5** (F2I9, 6.4 mg). Fraction F2I10 was purified by RP-HPLC using a mixture of MeOH/H~2~O (85/15 %v/v at 5.0 mL/min, flow rate) to afford **3** (1.0 mg) and **4** (1.0 mg), respectively.

Pinnisterol D (**1**): colorless oil; \[α\]${}_{D}^{25}$ +44 (*c* 1.3, CHCl~3~); IR (neat) ν~max~ 3446, 1741, 1685 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 1](#marinedrugs-15-00011-t001){ref-type="table"}); ESIMS *m*/*z* 525 \[M + Na\]^+^; HRESIMS *m*/*z* 525.31853 (calcd. for C~30~H~46~O~6~ + Na, 525.31921).

Pinnisterol E (**2**): colorless oil; \[α\]${}_{D}^{25}$ −35 (*c* 0.5, CHCl~3~); IR (neat) ν~max~ 3381, 1740, 1686 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 2](#marinedrugs-15-00011-t002){ref-type="table"} and [Table 3](#marinedrugs-15-00011-t003){ref-type="table"}); ESIMS *m*/*z* 527 \[M + Na\]^+^; HRESIMS *m*/*z* 527.33410 (calcd. for C~30~H~48~O~6~ + Na, 527.33486).

Pinnisterol F (**3**): colorless oil; \[α\]${}_{D}^{27}$ −152 (*c* 0.3, CHCl~3~); IR (neat) ν~max~ 3446, 1736, 1686 cm^−1^; ^1^H (700 MHz, CDCl~3~) and ^13^C (175 MHz, CDCl~3~) NMR data (see [Table 2](#marinedrugs-15-00011-t002){ref-type="table"} and [Table 3](#marinedrugs-15-00011-t003){ref-type="table"}); ESIMS *m*/*z* 583 \[M + Na\]^+^; HRESIMS *m*/*z* 583.32406 (calcd. for C~32~H~48~O~8~ + Na, 583.32469).

Pinnisterol G (**4**): colorless oil; \[α\]${}_{D}^{27}$ −176 (*c* 0.3, CHCl~3~); IR (neat) ν~max~ 3447, 1739, 1686 cm^−1^; ^1^H (700 MHz, CDCl~3~) and ^13^C (175 MHz, CDCl~3~) NMR data (see [Table 2](#marinedrugs-15-00011-t002){ref-type="table"} and [Table 3](#marinedrugs-15-00011-t003){ref-type="table"}); ESIMS *m*/*z* 583 \[M + Na\]^+^; HRESIMS *m*/*z* 583.32432 (calcd. for C~32~H~48~O~8~ + Na, 583.32469).

Pinnisterol H (**5**): colorless oil; \[α\]${}_{D}^{25}$ −20 (*c* 0.3, CHCl~3~); IR (neat) ν~max~ 3448, 1736, 1686 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 3](#marinedrugs-15-00011-t003){ref-type="table"} and [Table 4](#marinedrugs-15-00011-t004){ref-type="table"}); ESIMS *m*/*z* 585 \[M + Na\]^+^; HRESIMS *m*/*z* 585.33988 (calcd. for C~32~H~50~O~8~ + Na, 585.34034).

Pinnisterol I (**6**): colorless oil; \[α\]${}_{D}^{25}$ −129 (*c* 0.5, CHCl~3~); IR (neat) ν~max~ 3446, 1736, 1685 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 3](#marinedrugs-15-00011-t003){ref-type="table"} and [Table 4](#marinedrugs-15-00011-t004){ref-type="table"}); ESIMS *m*/*z* 585 \[M + Na\]^+^; HRESIMS *m*/*z* 585.33988 (calcd. for C~32~H~50~O~8~ + Na, 585.34034).

Pinnisterol J (**7**): colorless oil; \[α\]${}_{D}^{25}$ −5 (*c* 0.2, CHCl~3~); IR (neat) ν~max~ 3455, 1736, 1687 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 3](#marinedrugs-15-00011-t003){ref-type="table"} and [Table 4](#marinedrugs-15-00011-t004){ref-type="table"}); ESIMS *m*/*z* 583 \[M + Na\]^+^; HRESIMS *m*/*z* 583.32433 (calcd. for C~32~H~48~O~8~ + Na, 583.32469).

3.4. Anti-Hepatofibric Assay {#sec3dot4-marinedrugs-15-00011}
----------------------------

The anti-hepatofibric effects of secosterols **1**--**7**, at a concentration of 10 μM, were analyzed using a colorimetric assay (WST-1-based method). The steps of the assay were performed according to a previously-published method \[[@B14-marinedrugs-15-00011]\].

3.5. Generation of Superoxide Anions and Release of Elastase by Human Neutrophils {#sec3dot5-marinedrugs-15-00011}
---------------------------------------------------------------------------------

Human neutrophils were prepared by Ficoll centrifugation followed by dextran sedimentation. Measurements of superoxide anion generation and elastase release from neutrophils were performed based on published procedures \[[@B15-marinedrugs-15-00011],[@B16-marinedrugs-15-00011]\]. Briefly, MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide was used as the elastase substrate for the elastase release assay, and the method using superoxide dismutase-inhibitable reduction of ferricytochrome *c* was employed to measure superoxide anion production.

4. Conclusions {#sec4-marinedrugs-15-00011}
==============

Our ongoing investigations of coral metabolites showed that gorgonian corals belonging to the genus *Pinnigorgia* are rich in 9,11-secosterols. In cytotoxicity tests, secosterol **1** showed significant cytotoxicity against HSC-T6 cells. In anti-inflammatory activity tests on human neutrophils, secosterols **2**, **5**, and **7** displayed inhibitory effects on elastase release, and **3**, **5**, and **7** showed inhibitory effects on the generation of superoxide anions. Our findings suggested that these new 9,11-secosterols could be developed as promising bioactive agents, and further biomedical study is necessary in order to identify their potential applications in the treatment of disease.
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###### 

Results of ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR experiments and ^1^H--^1^H COSY and HMBC correlations for secosterol **1**.

  Position   δ~H~ (*J* in Hz)                    δ~C~, Multiple   ^1^H--^1^H COSY          HMBC
  ---------- ----------------------------------- ---------------- ------------------------ -------------------------------
  1          2.21 m; 1.78 m                      25.9, CH~2~      H~2~-2                   C-2, -10
  2          2.00 m; 1.49 m                      29.9, CH~2~      H~2~-1, H-3              n\. o. ^a^
  3          4.03 m                              66.7, CH         H~2~-2, H~2~-4           n\. o.
  4          2.17 m; 1.79 m                      35.7, CH~2~      H-3                      C-2, -3, -5, -6, -10
  5                                              80.6, C                                   
  6                                              197.5, C                                  
  7          6.45 s                              134.1, CH                                 C-5, -8, -9, -14
  8                                              152.0, C                                  
  9                                              201.6, C                                  
  10                                             52.0, C                                   
  11         4.18 m                              61.0, CH~2~      H~2~-12                  C-12, -13, acetate carbonyl
  12         1.68 m; 1.26 ddd (14.8, 9.2, 5.6)   37.1, CH~2~      H~2~-11                  C-11, -13, -14, -17, -18
  13                                             47.4, C                                   
  14         3.37 dd (10.8, 8.0)                 43.9, CH         H~2~-15                  C-7, -8, -9, -13, -15, -18
  15         1.75 m; 1.66 m                      27.1, CH~2~      H-14, H~2~-16            C-16
  16         1.78 m; 1.57 m                      25.6, CH~2~      H~2~-15, H-17            C-15
  17         1.81 m                              51.0, CH         H~2~-16, H-20            C-15, -16, -18, -21
  18         0.73 s                              18.0, CH~3~                               C-12, -13, -14, -17
  19         1.21 s                              20.5, CH~3~                               C-1, -5, -9, -10
  20         2.24 m                              38.3, CH         H-17, H~3~-21, H-22      C-16, -17, -22, -23
  21         1.05 d (6.8)                        21.8, CH~3~      H-20                     C-17, -20, -22
  22         5.23 dd (14.8, 6.8)                 133.8, CH        H-20, H-23               C-20, -24
  23         5.26 dd (14.8, 6.8)                 133.5, CH        H-22, H-24               C-20, -24
  24         1.86 m                              43.0, CH         H-23, H-25, H~3~-28      C-22, -23, -25, -26, -27, -28
  25         1.46 m                              33.1, CH         H-24, H~3~-26, H~3~-27   C-23, -24, -26, -27, -28
  26         0.84 d (7.2)                        20.0, CH~3~      H-25                     C-24, -25, -27
  27         0.82 d (7.2)                        19.7, CH~3~      H-25                     C-24, -25, -26
  28         0.91 d (6.8)                        17.5, CH~3~      H-24                     C-23, -24, -25
  11-OAc                                         171.1, C                                  
             2.02 s                              21.1, CH~3~                               Acetate carbonyl

^a^ n. o. = not observed.
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###### 

^1^H NMR data for secosterols **2**--**4**.

  δ~H~     2 ^a^                                   3 ^b^                                      4 ^b^
  -------- --------------------------------------- ------------------------------------------ ------------------------------------------
  1        2.21 m; 1.76 m                          2.21 m; 1.74 m                             2.20 m; 1.72 m
  2        2.00 m; 1.47 m                          2.00 m; 1.47 m                             2.00 m; 1.49 m
  3        4.04 m                                  4.04 m                                     4.04 m
  4        2.15 ddd (14.4, 5.2, 2.0) ^c^; 1.79 m   2.14 m; 1.77 m                             2.13 m; 1.79 m
  7        6.47 s                                  6.46 s                                     6.46 s
  11       4.16 m                                  4.17 t (6.3)                               4.18 m
  12       1.73 m; 1.23 m                          1.59 m; 1.30 m                             1.69 m; 1.25 m
  14       3.39 dd (10.8, 8.4)                     3.37 t (9.8)                               3.38 dd (11.2, 8.4)
  15       1.76 m; 1.68 m                          1.77 m; 1.69 m                             1.76 m; 1.65 m
  16       1.89 m; 1.53 m                          1.75 m; 1.49 m                             1.76 m; 1.55 m
  17       1.76 m                                  1.97 m                                     1.77 m
  18       0.74 s                                  0.73 s                                     0.73 s
  19       1.22 s                                  1.21 s                                     1.22 s
  20       1.42 m                                  1.46 m                                     2.23 m
  21       0.99 d (6.8)                            4.01 dd (10.5, 7.0); 3.96 dd (10.5, 7.0)   1.06 d (7.0)
  22       1.44 m; 0.95 m                          5.36 dd (15.4, 8.4)                        5.24 dd (15.4, 8.4)
  23       1.40 m; 0.96 m                          5.22 dd (15.4, 8.4)                        5.30 dd (15.4, 8.4)
  24       1.20 m                                  1.90 m                                     2.19 m
  25       1.61 m                                  1.45 m                                     1.71 m
  26       0.79 d (6.8)                            0.84 d (7.0)                               0.85 d (7.0)
  27       0.86 d (6.8)                            0.82 d (7.0)                               3.98 dd (10.5, 6.3); 3.85 dd (10.5, 6.3)
  28       0.78 d (6.8)                            0.93 d (7.0)                               0.98 d (7.0)
  11-OAc   2.02 s                                  2.02 s                                     2.03 s
  21-OAc                                           2.04 s                                     
  27-OAc                                                                                      2.07 s

^a^ Spectra recorded at 400 MHz in CDCl~3~; ^b^ Spectra recorded at 700 MHz in CDCl~3~; ^c^ *J* values (in Hz) in parentheses.
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###### 

^13^C NMR data for secosterols **2**--**7**.

  δ~C~     2 ^a^         3 ^b^         4 ^b^         5 ^a^         6 ^a^         7 ^a^
  -------- ------------- ------------- ------------- ------------- ------------- -------------
  1        25.9, CH~2~   25.8, CH~2~   25.9, CH~2~   25.9, CH~2~   25.7, CH~2~   25.7, CH~2~
  2        29.9, CH~2~   29.9, CH~2~   29.9, CH~2~   29.9, CH~2~   25.9, CH~2~   25.9, CH~2~
  3        66.7, CH      66.7, CH      66.7, CH      66.7, CH      69.7, CH      69.8, CH
  4        35.8, CH~2~   35.7, CH~2~   35.7, CH~2~   35.6, CH~2~   32.0, CH~2~   31.9, CH~2~
  5        80.6, C       80.6, C       80.6, C       80.5, C       80.1, C       80.0, C
  6        197.4, C      197.4, C      197.5, C      197.5, C      197.3, C      197.5, C
  7        134.1, CH     134.1, CH     134.1, CH     134.2, CH     134.2, CH     134.2, CH
  8        152.1, C      151.6, C      151.8, C      151.7, C      151.8, C      151.6, C
  9        201.5, C      201.6, C      201.6, C      201.6, C      201.2, C      201.3, C
  10       52.0, C       52.0, C       52.0, C       52.0, C       51.9, C       51.9, C
  11       61.0, CH~2~   60.8, CH~2~   61.0, CH~2~   60.9, CH~2~   61.0, CH~2~   61.0, CH~2~
  12       37.2, CH~2~   36.7, CH~2~   37.0, CH~2~   37.0, CH~2~   37.2, CH~2~   37.2, CH~2~
  13       47.5, C       47.5, C       47.3, C       47.4, C       47.4, C       47.4, C
  14       43.7, CH      43.5, CH      43.8, CH      43.7, CH      43.7, CH      43.8, CH
  15       27.2, CH~2~   27.1, CH~2~   26.9, CH~2~   27.0, CH~2~   27.1, CH~2~   27.1, CH~2~
  16       26.2, CH~2~   25.8, CH~2~   25.7, CH~2~   26.2, CH~2~   26.4, CH~2~   25.8, CH~2~
  17       50.7, CH      46.3, CH      50.7, CH      51.4, CH      51.6, CH      50.9, CH
  18       17.6, CH~3~   18.5, CH~3~   18.0, CH~3~   17.6, CH~3~   17.8, CH~3~   18.0, CH~3~
  19       20.5, CH~3~   20.4, CH~3~   20.5, CH~3~   20.4, CH~3~   20.3, CH~3~   20.2, CH~3~
  20       34.9, CH      42.2, CH      38.4, CH      33.2, CH      33.9, CH      38.2, CH
  21       19.2, CH~3~   67.2, CH~2~   21.7, CH~3~   20.4, CH~3~   21.1, CH~3~   21.6, CH~3~
  22       33.0, CH~2~   127.5, CH     135.4, CH     35.4, CH~2~   39.4, CH~2~   132.9, CH
  23       21.4, CH~2~   138.1, CH     131.1, CH     76.7, CH      74.6, CH      134.5, CH
  24       39.0, CH      43.4, CH      38.2, CH      42.7, CH      45.5, CH      75.0, C
  25       31.5, CH      32.9, CH      37.4, CH      28.5, CH      27.7, CH      38.1, CH
  26       17.6, CH~3~   20.0, CH~3~   13.1, CH~3~   21.6, CH~3~   21.7, CH~3~   17.5, CH~3~
  27       20.5, CH~3~   19.7, CH~3~   67.9, CH~2~   18.6, CH~3~   17.6, CH~3~   17.1, CH~3~
  28       15.4, CH~3~   17.5, CH~3~   18.3, CH~3~   11.0, CH~3~   10.5, CH~3~   25.2, CH~3~
  3-OAc                                                            170.8, C      170.9, C
                                                                   21.3, CH~3~   21.1, CH~3~
  11-OAc   171.1, C      171.1, C      171.1, C      171.1, C      171.0, C      170.9, C
           21.1, CH~3~   21.1, CH~3~   21.1, CH~3~   21.1, CH~3~   21.1, CH~3~   21.1, CH~3~
  21-OAc                 171.1, C                                                
                         21.0, CH~3~                                             
  23-OAc                                             170.7, C                    
                                                     21.4, CH~3~                 
  27-OAc                               171.3, C                                  
                                       21.1, CH~3~                               

^a^ Spectra recorded at 100 MHz in CDCl~3~; ^b^ Spectra recorded at 175 MHz in CDCl~3~.
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###### 

^1^H NMR (400 MHz, CDCl~3~) data for secosterols **5**--**7**.

  δ~H~     5                         6                     7
  -------- ------------------------- --------------------- ---------------------
  1        2.22 m; 1.76 m            2.27 m; 1.78 m        2.28 m; 1.76 m
  2        1.97 m; 1.48 m            1.98 m; 1.60 m        1.96 m; 1.61 m
  3        4.02 m                    5.05 m                5.05 m
  4        2.12 m; 1.78 m            2.24 m; 1.81 m        2.24 m; 1.79 m
  7        6.45 s                    6.46 s                6.45 s
  11       4.14 m                    4.18 m                4.17 m
  12       1.63 m; 1.23 m            1.70 m; 1.27 m        1.67 m; 1.26 m
  14       3.36 dd (11.2, 8.4) ^a^   3.39 dd (10.8, 8.0)   3.39 dd (10.4, 8.0)
  15       1.76 m; 1.65 m            1.80 m; 1.69 m        1.76 m; 1.69 m
  16       1.91 m; 1.52 m            1.93 m; 1.53 m        1.99 m; 1.53 m
  17       1.69 m                    1.81 m                1.81 m
  18       0.73 s                    0.74 s                0.73 s
  19       1.20 s                    1.22 s                1.21 s
  20       1.54 m                    1.63 m                2.28 m
  21       1.02 d (6.8)              1.13 d (6.8)          1.08 d (6.8)
  22       1.67 m; 1.24 m            1.72 m; 1.07 m        5.53 dd (15.6, 8.4)
  23       5.01 m                    3.59 m                5.48 (15.6)
  24       1.47 m                    1.32 m                
  25       1.57 m                    1.84 m                1.67 m
  26       0.93 d (6.8)              0.94 d (7.2)          0.89 d (6.8)
  27       0.83 d (6.8)              0.84 d (7.2)          0.88 d (6.8)
  28       0.81 d (6.8)              0.79 d (7.2)          1.21 s
  3-OAc                              2.04 s                2.04 s
  11-OAc   2.02 s                    2.02 s                2.02 s
  23-OAc   2.03 s                                          

^a^ *J* values (in Hz) in parentheses.

marinedrugs-15-00011-t005_Table 5

###### 

Inhibitory effects of secosterols **2**--**7** on elastase release and superoxide anion generation by human neutrophils in response to fMet-Leu-Phe/Cytochalastin B.

  Compound   Elastase Release   Superoxide Anions
  ---------- ------------------ -------------------
  **2**      2.33 ± 0.27        \>10
  **3**      \>10               5.52 ± 1.06
  **4**      \>10               \>10
  **5**      2.59 ± 0.29        3.26 ± 0.33
  **6**      \>10               \>10
  **7**      3.89 ± 1.16        3.71 ± 0.51

[^1]: These authors contributed equally to this work.
